Bosnalijek

Bosnalijek
Public (SASE: BSNLR)
Industry Pharmaceutical
Founded 1951
Headquarters Sarajevo, Bosnia and Herzegovina
Key people
 Edin Arslanagić (Chief Executive Officer)
Products Solid oral form medicines, ampule medicines, galenic products, non-pharmaceutical chemical products
Revenue Increase 88,056 million BAM (2007)[1]
7,796 million BAM (2007)[1]
Number of employees
 ~620 (2009)
Website http://www.bosnalijek.ba/

Bosnalijek is the largest pharmaceutical company in Bosnia and Herzegovina. The organisation was established in 1951 and employs ~620 workers, out of which more than 50% have university level or higher qualifications. Its product portfolio consists of ~180 products. The company continues investment into R&D. Bosnalijek has established collaboration with several world-leading companies from the industry.[2]

Bosnalijek is present in 22 countries worldwide: all neighbouring southeastern European countries, most eastern European countries, Libya and many French-speaking African countries, several countries from the Arabian peninsula and Caucasus, etc.[3]

In 2005, International Finance Corporation provided Bosnalijek with a €7.5 million loan for the construction of an €18.5 million production and distribution center.[4]

References

  1. 1 2 Bosnalijek - 2007 financial report
  2. ↑ Short overview of Bosnalijek
  3. ↑ Bosnalijek worldwide
  4. ↑ Summary of Project Information, Project Number 24017, International Finance Corporation, World Bank Group. Accessed 2008-01-14.
Wikimedia Commons has media related to Bosnalijek.
This article is issued from Wikipedia - version of the 11/6/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.